These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 12848369)
1. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XVI. Derivatives of 1-acetoxy-7,7-dimethylbicyclo[2.2.2]octan-5-one-2,3-dicarboximide. Kossakowski J; Hejchman E Acta Pol Pharm; 2003; 60(1):61-6. PubMed ID: 12848369 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of new derivatives of 1,2,3,4,7-pentamethylbicyclo[2.2.1]hept-2-ene-5,6-dicarboximide with an expected anxiolytic activity. Kossakowski J; Kuśmierczyk J Pharmazie; 2000 Jan; 55(1):5-8. PubMed ID: 10683863 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of new N-[4-(4-aryl- and 4-heteroaryl-1-piperazinyl)butyl]derivatives of 1-methyl-5-oxobicyclo[2.2.1]heptane-2,3-dicarboximide with an expected anxiolytic activity. Kossakowski J; Zawadowski T; Kuśmierczyk J Acta Pol Pharm; 1998; 55(4):315-8. PubMed ID: 9821397 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XV. Derivatives of 2-ethyl-1.4-dimethoxy-dibenzo[e.h]bicyclo[2.2.2] octane-2.3-dicarboximide. Kossakowski J; Maleszewska E Acta Pol Pharm; 2000 Nov; 57 Suppl():47-50. PubMed ID: 11293262 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of new n-substituted cyclic imides with potential anxiolytic activity. XVIII. Derivatives of 1-bromo-dibenzo[e.h]bicyclo[2.2.2] octane-2.3-dicarboximide. Kossakowski J; Perliński M Acta Pol Pharm; 2001; 58(4):257-62. PubMed ID: 11693729 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of new N-substituted cyclic imides with potential anxiolytic activity. XXV. Derivatives of halogenodibenzo[e.h]bicyclo[2.2.2]octane-2.3-dicarboximide. Kossakowski J; Perliński M Acta Pol Pharm; 2003; 60(3):183-90. PubMed ID: 14556486 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XXIV. Derivatives of N-hydroxy-1-methoxybicyclo[2.2.2]oct-5-ene-2,3-dicarboximide. Kossakowski J; Krawiecka M Acta Pol Pharm; 2003; 60(3):177-82. PubMed ID: 14556485 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XII. Derivatives of N-hydroxy-1,4-dimethyl-dibenzo[e.h]bicyclo[2.2.2]-octane-2,3-dicarboximide. Kossakowski J; Jarocka M Acta Pol Pharm; 2000 Nov; 57 Suppl():60-2. PubMed ID: 11293267 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anxiolytic activity of N-substituted cyclic imides N-[4-[(4-aryl)-1-piperazinyl]alkyl]-5,7-dioxabicyclo[2.2.2]octane-2, 3-dicarboximide. Zawadowski T; Kossakowski J; Rump S; Jakowicz I; Płaźnik A Acta Pol Pharm; 1995; 52(1):43-6. PubMed ID: 8960237 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XXII. Derivatives of 1-methoxy-5-bicyclo[2.2.2]-oct-5-one-2,3-dicarboximide. Kossakowski J; Jarocka-Wierzba M Acta Pol Pharm; 2003; 60(5):367-74. PubMed ID: 15005420 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XIV. Derivatives of 1.4-diethoxy-dibenzo[e.h]bicyclo[2.2.2]octane-2.3-dicarboximide. Kossakowski J; Maleszewska E Acta Pol Pharm; 2000 Nov; 57 Suppl():50-3. PubMed ID: 11293264 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XIII. Derivatives of 1-methoxybicyclo[2.2.2]oct-5-ene-2,3-dicarboximide. Kossakowski J; Krawiecka M Acta Pol Pharm; 2000 Nov; 57 Suppl():53-6. PubMed ID: 11293265 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XI. Derivatives of 7-diphenylmethylenebicyclo[2.2.1]hept-2-ene-5,6-dicarboximide. Kossakowski J; Hejchman E Acta Pol Pharm; 2000 Nov; 57 Suppl():57-60. PubMed ID: 11293266 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of new N-substituted cyclic imides with an expected anxiolytic activity. XVII. Derivatives of 1-ethoxybicyclo[2.2.2]-oct-5-one-2,3-dicarboximide. Kossakowski J; Jarocka M Farmaco; 2001 Oct; 56(10):785-9. PubMed ID: 11718272 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological screening of some N,N'-bis-[4-(4-aryl-1-piperazinyl)butyl]-substituted derivatives of 1,8-dimethylbicyclo-[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide. Turło J; Zawadowski T; Rump S; Jakowicz I; Gidyńska T; Gałecka E Pol J Pharmacol; 1994; 46(5):451-5. PubMed ID: 7894533 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of new n-substituted cyclic imides with potential anxiolytic activity. XXIII. Derivatives of 2'-chlorodibenzo[e.h]bicyclo[2.2.2]octane-2,3-dicarboximide. Kossakowski J; Perliński M Acta Pol Pharm; 2002; 59(6):423-7. PubMed ID: 12669763 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and anxiolytic activity of N-substituted cyclic imides (1R*,2S*,3R*,4S*)-N-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,3- bicyclo[2.2.1]heptanedicarboximide (tandospirone) and related compounds. Ishizumi K; Kojima A; Antoku F Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2288-300. PubMed ID: 1687114 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of new N-substituted cyclic imides with expected anxiolytic activity. XXI. Derivatives of 1,4-dibromo-dibenzo[e.h]bicyclo[2.2.2]octane-2,3-dicarboximide. Kossakowski J; Krawiecka M; Perliński M Acta Pol Pharm; 2002; 59(1):37-43. PubMed ID: 12026111 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of new n-substituted cyclic imides with expected anxiolytic activity. XXI. Derivatives of 1-acetyldibenzo-[e.h]-bicyclo[2.2.2]-octane-2,3-dicarboximide. Kossakowski J; Szczepek W; Pakosińska-Parys M Acta Pol Pharm; 2002; 59(6):418-23. PubMed ID: 12669762 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of some N-substituted derivatives of dibenzo[e.h]bicyclo[2.2.2]octane-2,3-dicarboximide with an expected activity on central nervous system. Zawadowski T; Zadrozna A; Rump S; Jakowicz I Acta Pol Pharm; 1994; 51(6):467-70. PubMed ID: 7762397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]